Trevi Therapeutics, Inc. — All Filings
513 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002401 | Mar 27, 2026 | — |
| 10-K | 10-K | 0001193125-26-110783 | Mar 17, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-110767 | Mar 17, 2026 | — |
| 8-K | 8-K | 0001193125-26-098676 | Mar 9, 2026 | — |
| 4 | 4 | 0001193125-26-061399 | Feb 20, 2026 | Feb 19, 2026 |
| 4 | 4 | 0001193125-26-061396 | Feb 20, 2026 | Feb 19, 2026 |
| 4 | 4 | 0001193125-26-061394 | Feb 20, 2026 | Feb 19, 2026 |
| 4 | 4 | 0001193125-26-061391 | Feb 20, 2026 | Feb 19, 2026 |
| 4 | 4 | 0001193125-26-061385 | Feb 20, 2026 | Feb 19, 2026 |
| 5 | 5 | 0001193125-26-051548 | Feb 13, 2026 | Dec 31, 2025 |
| 5 | 5 | 0001193125-26-051530 | Feb 13, 2026 | Dec 31, 2025 |
| 5 | 5 | 0001193125-26-051545 | Feb 13, 2026 | Dec 31, 2025 |
| 5 | 5 | 0001193125-26-051528 | Feb 13, 2026 | Dec 31, 2025 |
| 5 | 5 | 0001193125-26-051525 | Feb 13, 2026 | Dec 31, 2025 |
| 5 | 5 | 0001193125-26-051520 | Feb 13, 2026 | Dec 31, 2025 |
| 5 | 5 | 0001193125-26-051537 | Feb 13, 2026 | Dec 31, 2025 |
| 5 | 5 | 0001193125-26-051517 | Feb 13, 2026 | Dec 31, 2025 |
| SCHEDULE 13G/A | — | 0001104659-26-015247 | Feb 13, 2026 | — |
| SCHEDULE 13D/A | — | 0001072613-26-000150 | Feb 13, 2026 | — |
| SCHEDULE 13G | — | 0000315066-26-000550 | Feb 5, 2026 | — |
| SCHEDULE 13G | — | 0000102909-26-000259 | Jan 30, 2026 | — |
| 4 | 4 | 0001193125-26-010361 | Jan 12, 2026 | Jan 8, 2026 |
| 3 | 3 | 0001193125-26-010351 | Jan 12, 2026 | Jan 8, 2026 |
| 8-K | 8-K | 0001193125-25-308769 | Dec 5, 2025 | Dec 1, 2025 |
| 4 | 4 | 0001193125-25-306729 | Dec 3, 2025 | Dec 2, 2025 |
| SCHEDULE 13G/A | — | 0000905148-25-004065 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001231919-25-000495 | Nov 14, 2025 | — |
| S-3ASR | S-3ASR | 0001193125-25-280501 | Nov 13, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-280166 | Nov 13, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-280149 | Nov 13, 2025 | — |
| SCHEDULE 13G | — | 0002012383-25-002719 | Oct 17, 2025 | — |
| 144 | — | 0001972481-25-000242 | Oct 7, 2025 | — |
| 144 | — | 0001972481-25-000235 | Oct 3, 2025 | — |
| 144 | — | 0001972481-25-000182 | Aug 27, 2025 | — |
| 8-K | 8-K | 0001563880-25-000005 | Aug 20, 2025 | Aug 14, 2025 |
| SCHEDULE 13G/A | — | 0000905148-25-002998 | Aug 14, 2025 | — |
| SCHEDULE 13D/A | — | 0001072613-25-000533 | Aug 11, 2025 | — |
| S-8 | S-8 | 0000950170-25-105074 | Aug 7, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-105066 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-105011 | Aug 7, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-066695 | Jul 9, 2025 | — |
| 8-K | 8-K | 0000950170-25-087486 | Jun 17, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086165 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086112 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086111 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086110 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086109 | Jun 13, 2025 | Jun 11, 2025 |
| 8-K | 8-K | 0001193125-25-134913 | Jun 4, 2025 | Jun 3, 2025 |
| 424B5 | 424B5 | 0001193125-25-134905 | Jun 4, 2025 | — |
| 4 | 4 | 0000950170-25-080889 | Jun 3, 2025 | May 31, 2025 |